Does VEDOLIZUMAB Cause Nasopharyngitis? 2,132 Reports in FDA Database

Q: Does VEDOLIZUMAB cause Nasopharyngitis?

2,132 reports of Nasopharyngitis have been filed with the FDA for VEDOLIZUMAB, representing 2.9% of all VEDOLIZUMAB adverse event reports.

Q: How dangerous is Nasopharyngitis from VEDOLIZUMAB?

Of 2,132 reports, 337 (15.8%) resulted in death and 748 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 2,132 reports of Nasopharyngitis have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 2.9% of all adverse event reports for VEDOLIZUMAB.

2,132

Reports of Nasopharyngitis with VEDOLIZUMAB

2.9%

of all VEDOLIZUMAB reports

337

Deaths

748

Hospitalizations

How Dangerous Is Nasopharyngitis From VEDOLIZUMAB?

Of the 2,132 reports, 337 (15.8%) resulted in death, 748 (35.1%) required hospitalization, and 270 (12.7%) were considered life-threatening.